6-((7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthamide,
orteronel,
TAK-700,
Orteronel,
566939-85-3,
TAK-700,
UNII-UE5K2FNS92,
TAK 700,
UE5K2FNS92,
TAK700,
CHEMBL1921976,
TAK-700 (Orteronel),
(S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide,
6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide,
6-((7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthalenecarboxamide,
TAK-700 (S-form),
Orteronel [USAN:INN],
6-[(7S)-7-HYDROXY-6,7-DIHYDRO-5H-PYRROLO[1,2-C]IMIDAZOL-7-YL]-N-METHYL-2-NAPHTHALENECARBOXAMIDE,
Orteronel (JAN/USAN),
TAK-700 - Orteronel,
TAK700 (S-Enantiomer),
SCHEMBL6126076,
566939-85-3,Orteronel,
AOB5527,
EX-A159,
csa:566939-85-3;Orteronel,
ZINC3943521,
Orteronel,CAS:566939-85-3,
BDBM50358201,
AKOS030526849,
CS-0580,
DB12066,
RL04142,
SB16686,
NCGC00378767-02,
AJ-47464,
HY-10505,
AB0165761,
FT-0773259,
D10146,
S-7761,
J-523835,
6-[(7s)-7-hydroxy-6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide,
6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide,
6-[(7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide,
(S)-Orteronel,
Orteronel [INN],
TAK-700 R-form,
cc-589,
CID9796590,
A3686,
A4326,
B1194,
C571806,
426219-18-3,
(R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide,
6-((7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthamide,
2-Naphthalenecarboxamide, 6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-,
6-(6-hydroxy-1,3-diazabicyclo[3.3.0]octa-2,4-dien-6-yl)-N-methyl-naphthalene-2-carboxamide,
752243-39-3,